8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with sb-224289 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Eddershaw, PJ; Gordon, LJ; Lovell, PJ; Moore, SH; Scott, CM; Smith, PW; Starr, KR; Thewlis, KM; Ward, SE; Watson, JM | 1 |
2 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and sb-224289
| Article | Year |
|---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.
Topics: Animals; Blood-Brain Barrier; Cerebral Cortex; Humans; In Vitro Techniques; Piperazines; Quinolines; Radioligand Assay; Rats; Recombinant Proteins; Serotonin 5-HT1 Receptor Antagonists; Structure-Activity Relationship | 2008 |